(Q74652227)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096977%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096977%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

2

Mollnes TE

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096977%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

4

Fosse E

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096977%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Videm V

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096977%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Bergh K

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096977%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Mohr B

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096977%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Hagve TA

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096977%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Aasen AO

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096977%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Svennevig JL

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096977%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

English

0 references

publication date

1 April 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096977%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Thoracic and Cardiovascular Surgery

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096977%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096977%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096977%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

803-809

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096977%20AND%20SRC:MED&resulttype=core&format=json

Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970302-8

Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970302-8

Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970302-8

A neoepitope-based enzyme immunoassay for quantification of C1-inhibitor in complex with C1r and C1s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970302-8

Production of monoclonal antibodies against the human anaphylatoxin C5a des Arg and their application in the neoepitope-specific sandwich-ELISA for the quantification of C5a des Arg in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970302-8

Evaluation of hemoconcentration from hematocrit measurements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970302-8

Complement activation before, during and after cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970302-8

Modification of the complement binding properties of polystyrene: effects of end-point heparin attachment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970302-8

A postulated mechanism for heparin's potentiation of C1 inhibitor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970302-8

Specific complement inhibition with heparin-coated extracorporeal circuits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970302-8

Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970302-8

Complement activation during bypass in acquired C1 esterase inhibitor deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970302-8

Potentiation of factor H by heparin: A rate-limiting mechanism for inhibition of the alternative complement pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970302-8

Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970302-8

Novel purification of vitronectin from human plasma by heparin affinity chromatography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970302-8

A New Model for Evaluation of Biocompatibility: Combined Determination of Neoepitopes in Blood and on Artificial Surfaces Demonstrates Reduced Complement Activation by Immobilization of Heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970302-8

Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970302-8

Both plasma- and leukocyte-associated C5a are essential for assessment of C5a generation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970302-8

Early- and late-phase activation of complement evaluated by plasma levels of C3d,g and the terminal complement complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970302-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-5223(99)70302-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096977%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference